These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1921484)

  • 1. Omega-3 polyunsaturated fatty acids: a potential new treatment of immune renal disease.
    Donadio JV
    Mayo Clin Proc; 1991 Oct; 66(10):1018-28. PubMed ID: 1921484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Omega-3 polyunsaturated fatty acids in the treatment of kidney disease.
    Fassett RG; Gobe GC; Peake JM; Coombes JS
    Am J Kidney Dis; 2010 Oct; 56(4):728-42. PubMed ID: 20493605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Marine lipids: overview "news insights and lipid composition of Lyprinol".
    Sinclair AJ; Murphy KJ; Li D
    Allerg Immunol (Paris); 2000 Sep; 32(7):261-71. PubMed ID: 11094639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purified omega-3 fatty acids retard the development of proteinuria in salt-loaded hypertensive rats.
    Rayner TE; Howe PR
    J Hypertens; 1995 Jul; 13(7):771-80. PubMed ID: 7594441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Essential fatty acid deficiency profiles in idiopathic immunoglobulin A nephropathy.
    Holman RT; Johnson SB; Bibus D; Spencer DC; Donadio JV
    Am J Kidney Dis; 1994 May; 23(5):648-54. PubMed ID: 8172206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Omega-3 fatty acid supplementation in clinical and experimental lupus nephritis.
    Clark WF; Parbtani A
    Am J Kidney Dis; 1994 May; 23(5):644-7. PubMed ID: 8172205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Omega-3 polyunsaturated fatty acids in the prevention of atherosclerosis].
    Varga Z
    Orv Hetil; 2008 Apr; 149(14):627-37. PubMed ID: 18375362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of omega-3 polyunsaturated fatty acids on cardiac rhythm: a critical reassessment.
    Billman GE
    Pharmacol Ther; 2013 Oct; 140(1):53-80. PubMed ID: 23735203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic potential of omega-3 fatty acid-derived epoxyeicosanoids in cardiovascular and inflammatory diseases.
    Schunck WH; Konkel A; Fischer R; Weylandt KH
    Pharmacol Ther; 2018 Mar; 183():177-204. PubMed ID: 29080699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. n-3 fatty acids and renal diseases.
    De Caterina R; Endres S; Kristensen SD; Schmidt EB
    Am J Kidney Dis; 1994 Sep; 24(3):397-415. PubMed ID: 8079965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dietary supplementation with eicosapentaenoic acid, but not with other long-chain n-3 or n-6 polyunsaturated fatty acids, decreases natural killer cell activity in healthy subjects aged >55 y.
    Thies F; Nebe-von-Caron G; Powell JR; Yaqoob P; Newsholme EA; Calder PC
    Am J Clin Nutr; 2001 Mar; 73(3):539-48. PubMed ID: 11237929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of ischemia-induced ventricular fibrillation by omega 3 fatty acids.
    Billman GE; Hallaq H; Leaf A
    Proc Natl Acad Sci U S A; 1994 May; 91(10):4427-30. PubMed ID: 8183925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. n-3 polyunsaturated fatty acids: update 1995.
    Endres S; De Caterina R; Schmidt EB; Kristensen SD
    Eur J Clin Invest; 1995 Sep; 25(9):629-38. PubMed ID: 7498235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do we need 'new' omega-3 polyunsaturated fatty acids formulations?
    Cicero AF; Morbini M; Borghi C
    Expert Opin Pharmacother; 2015 Feb; 16(3):285-8. PubMed ID: 25474717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Omega-3 polyunsaturated fatty acids in treating non-alcoholic steatohepatitis: A randomized, double-blind, placebo-controlled trial.
    Nogueira MA; Oliveira CP; Ferreira Alves VA; Stefano JT; Rodrigues LS; Torrinhas RS; Cogliati B; Barbeiro H; Carrilho FJ; Waitzberg DL
    Clin Nutr; 2016 Jun; 35(3):578-86. PubMed ID: 26047766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fish oil supplementation alters circulating eicosanoid concentrations in young healthy men.
    Zulyniak MA; Perreault M; Gerling C; Spriet LL; Mutch DM
    Metabolism; 2013 Aug; 62(8):1107-13. PubMed ID: 23522836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dietary long-chain polyunsaturated fatty acids influence the recovery of thioacetamide-induced liver cirrhosis in rats.
    Moreira E; Fontana L; Torres MI; Fernández I; Ríos A; Sánchez de Medina F; Gil A
    JPEN J Parenter Enteral Nutr; 1995; 19(6):461-9. PubMed ID: 8748360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. n-3 polyunsaturated fatty acids and autoimmune-mediated glomerulonephritis.
    Pestka JJ
    Prostaglandins Leukot Essent Fatty Acids; 2010; 82(4-6):251-8. PubMed ID: 20189790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Periodontal disease: modulation of the inflammatory cascade by dietary n-3 polyunsaturated fatty acids.
    Sculley DV
    J Periodontal Res; 2014 Jun; 49(3):277-81. PubMed ID: 23889472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Omega-3 and omega-6 polyunsaturated fatty acids: Dietary sources, metabolism, and significance - A review.
    Saini RK; Keum YS
    Life Sci; 2018 Jun; 203():255-267. PubMed ID: 29715470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.